Currently out of the existing stock ratings of Suraj Kalia, 185 are a BUY (79.06%), 28 are a HOLD (11.97%), 21 are a SELL (8.97%).

Suraj Kalia

Work Performance Price Targets & Ratings Chart

Analyst Suraj Kalia, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 57.52% that have a potential upside of 34.89% achieved within 239 days.

Suraj Kalia’s has documented 444 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Industrials, Technology, Consumer Cyclical sectors.

Most recent stock forecast was given on VREX, Varex Imaging Corp at 11-Aug-2026.

Wall Street Analyst Suraj Kalia

Analyst best performing recommendations are on ATRC (ATRICURE).
The best stock recommendation documented was for ATRC (ATRICURE) at 4/28/2021. The price target of $75 was fulfilled within 1 day with a profit of $5.15 (7.37%) receiving and performance score of 73.73.

Average potential price target upside

of $115.43 (41.15%) on SWAV (SHOCKWAVE MEDICAL).
of $36.02 (37.51%) on IRTC (IRHYTHM TECHNOLOGIES).
of $32.5 (36.57%) on INSP (INSPIRE MEDICAL SYSTEMS).

ABMD ABIOMED ATRC AtriCure BLFS BioLife Solutions CRY CryoLife CSII Cardiovascular Systems EW Edwards Lifesciences Corp INSP Inspire Medical Systems IRTC iRhythm Technologies ISR IsoRay ISRG Intuitive Surgical NVRO Nevro Corp RMD ResMed TCMD Tactile Systems Technology TMDX TransMedics Group VRAY ViewRay APEN Apollo Endosurgery DXCM DexCom PODD Insulet HUMA Humacyte AORT Artivion IRT Independence Realty Trust NYXH Nyxoah SWAV Shockwave Medical VREX Varex Imaging Corp BFLY Butterfly Network TMDI Titan Medical VERO Venus Concept XAIR Beyond Air XENT Intersect ENT RSLS ReShape Lifesciences SILK Silk Road Medical ITGR Integer Holdings Corp MDXG MiMedx Group ABT Abbott Laboratories LMAT LeMaitre Vascular OBLN Obalon Therapeutics BSX Boston Scientific Corp OM Outset Medical PRCT Procept Biorobotics Corp BAX Baxter International CR Crane Company EDAP EDAP TMS SA TARS Tarsus Pharmaceuticals VERX Vertex VRA Vera Bradley

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Cecilia Furlong